$GLAE
GlassBridge Enterprises, Inc.

2023 Q2 Form 10-Q Financial Statement

#000149315223017406 Filed on May 15, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q4
Revenue $100.0K $100.0K
YoY Change 0.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.100M $1.100M $800.0K
YoY Change 37.5% 37.5% -500.0%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00
YoY Change
% of Gross Profit
Operating Expenses $1.100M $1.100M $800.0K
YoY Change 37.5% 37.5% -500.0%
Operating Profit -$1.100M -$1.000M
YoY Change 37.5% 25.0%
Interest Expense $100.0K $100.0K -$100.0K
YoY Change -200.0% -200.0%
% of Operating Profit
Other Income/Expense, Net -$100.0K $100.0K
YoY Change
Pretax Income -$1.100M -$1.100M -$700.0K
YoY Change 57.14% 37.5% -110.0%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.100M -$1.100M -$700.0K
YoY Change 57.14% 37.5% -103.14%
Net Earnings / Revenue -1100.0% -700.0%
Basic Earnings Per Share -$41.66 -$41.67
Diluted Earnings Per Share -$41.66 -$41.67 -$26.52
COMMON SHARES
Basic Shares Outstanding 25.17K shares 25.17K shares 25.17K shares
Diluted Shares Outstanding 26.40K shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $500.0K $900.0K $1.200M
YoY Change -80.77% -71.88% -70.73%
Cash & Equivalents $200.0K $600.0K $1.200M
Short-Term Investments $300.0K $300.0K
Other Short-Term Assets $300.0K $300.0K $0.00
YoY Change
Inventory
Prepaid Expenses
Receivables $100.0K $100.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $500.0K $1.000M $1.300M
YoY Change -81.48% -69.7% -69.05%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $12.50M $12.50M $12.80M
YoY Change -2.34% -2.34% 0.0%
Other Assets $600.0K $600.0K $500.0K
YoY Change 20.0% 20.0% 150.0%
Total Long-Term Assets $13.10M $13.10M $13.30M
YoY Change -1.5% -1.5% 2.31%
TOTAL ASSETS
Total Short-Term Assets $500.0K $1.000M $1.300M
Total Long-Term Assets $13.10M $13.10M $13.30M
Total Assets $13.60M $14.10M $14.60M
YoY Change -15.0% -15.06% -15.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.200M $1.700M $1.200M
YoY Change 69.23% 41.67% 9.09%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.600M $2.100M $1.600M
YoY Change 52.94% 31.25% 6.67%
LONG-TERM LIABILITIES
Long-Term Debt $3.900M $3.800M $3.700M
YoY Change 11.43% 8.57% 8.82%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $3.900M $3.800M $3.700M
YoY Change 1850.0% 2.7% 1750.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.600M $2.100M $1.600M
Total Long-Term Liabilities $3.900M $3.800M $3.700M
Total Liabilities $6.700M $6.100M $5.500M
YoY Change 24.07% 15.09% 7.84%
SHAREHOLDERS EQUITY
Retained Earnings -$1.041B -$1.040B -$1.039B
YoY Change 0.36% 0.29%
Common Stock $0.00 $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $24.90M $24.90M $24.90M
YoY Change 0.0% 0.0%
Treasury Stock Shares 2.927K shares
Shareholders Equity $6.900M $8.000M $9.100M
YoY Change
Total Liabilities & Shareholders Equity $13.60M $14.10M $14.60M
YoY Change -15.0% -15.06% -15.12%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q4
OPERATING ACTIVITIES
Net Income -$1.100M -$1.100M -$700.0K
YoY Change 57.14% 37.5% -103.14%
Depreciation, Depletion And Amortization $0.00
YoY Change
Cash From Operating Activities -$400.0K -$600.0K -$700.0K
YoY Change -33.33% -14.29% -66.67%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities $0.00 $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -400.0K -$600.0K -700.0K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 0.000 0.000
Net Change In Cash -400.0K -$600.0K -700.0K
YoY Change -33.33% -125.0%
FREE CASH FLOW
Cash From Operating Activities -$400.0K -$600.0K -$700.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001014111
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
usd
CY2022Q1 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
usd
CY2023Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022Q1 GLAE Marketable Securities Received From Distribution
MarketableSecuritiesReceivedFromDistribution
usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
usd
CY2022Q4 us-gaap Marketable Securities
MarketableSecurities
usd
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
1-14310
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
GLASSBRIDGE ENTERPRISES, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
41-1838504
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
18 East 50th Street
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
FL7
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10022
CY2023Q1 dei City Area Code
CityAreaCode
(212)
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
220-3300
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25170 shares
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
100000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1100000 usd
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
800000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
1100000 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
800000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1000000.0 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-800000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
100000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
100000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
100000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-100000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1100000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-800000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1100000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-800000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-41.67
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-30.30
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26400 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26400 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
600000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1200000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
100000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
100000 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
300000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
1000000.0 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1300000 usd
CY2023Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
12500000 usd
CY2022Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
12800000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
600000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
500000 usd
CY2023Q1 us-gaap Assets
Assets
14100000 usd
CY2022Q4 us-gaap Assets
Assets
14600000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1700000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1200000 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
400000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
400000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2100000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1600000 usd
CY2023Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
3800000 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
3700000 usd
CY2023Q1 GLAE Deferred Taxes Liabilities Noncurrent
DeferredTaxesLiabilitiesNoncurrent
200000 usd
CY2022Q4 GLAE Deferred Taxes Liabilities Noncurrent
DeferredTaxesLiabilitiesNoncurrent
200000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
6100000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
5500000 usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28097 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28097 shares
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1073000000.0 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1073000000.0 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1040100000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1039000000.0 usd
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
2927 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
2927 shares
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
24900000 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
24900000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
8000000.0 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
9100000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14100000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14600000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9100000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8000000.0 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
12100000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
12100000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11300000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11300000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1100000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-800000 usd
CY2023Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
100000 usd
CY2022Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
100000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-400000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-600000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-700000 usd
CY2022Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
200000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-200000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-600000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-900000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1200000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4100000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
600000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3200000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
100000 usd
CY2023Q1 GLAE Marketable Securities Received From Distribution
MarketableSecuritiesReceivedFromDistribution
300000 usd
CY2023Q1 GLAE Marketable Securities Received From Distribution
MarketableSecuritiesReceivedFromDistribution
300000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1360 shares
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1100000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-800000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26400 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26400 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-41.67
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-30.30
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
300000 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
400000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
400000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
200000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
200000 usd
CY2023Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
12500000 usd
CY2021Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
12800000 usd
CY2023Q1 us-gaap Management Fee Description
ManagementFeeDescription
the Company is entitled to receive between 18% and 20% of all general partner consideration on pooled investment vehicles managed by Arrive, whether characterized as management fees or incentive fees
CY2023Q1 us-gaap Investments And Other Noncurrent Assets
InvestmentsAndOtherNoncurrentAssets
600000 usd
CY2022Q4 us-gaap Investments And Other Noncurrent Assets
InvestmentsAndOtherNoncurrentAssets
500000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
4000000.0 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
3900000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
3800000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
200000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
4000000.0 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1360 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
106.00
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1360 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
106.00
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1360 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
106.00
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1360 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0.0 usd
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0.0 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-1100000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0.0 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-800000 usd
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1000000.0 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-800000 usd
CY2023Q1 us-gaap Assets
Assets
14100000 usd
CY2022Q4 us-gaap Assets
Assets
14600000 usd
CY2023Q1 us-gaap Marketable Securities
MarketableSecurities
300000 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
glae-20230331_def.xml Edgar Link unprocessable
0001493152-23-017406-index-headers.html Edgar Link pending
0001493152-23-017406-index.html Edgar Link pending
0001493152-23-017406.txt Edgar Link pending
0001493152-23-017406-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
form10-q_001.jpg Edgar Link pending
glae-20230331.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
glae-20230331_cal.xml Edgar Link unprocessable
glae-20230331_lab.xml Edgar Link unprocessable
glae-20230331_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending